NRN. V. Rubtsov

N. V. Rubtsov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


N. V. Rubtsov has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Mechanical Circulatory Support in Patients with End-Stage Heart Failure: a Literature Review (Part 2)

    by M. Sh. Khubutiya, A. S. Tokarev, N. V. Rubtsov, M. V. Israpiev, I. G. Khutsishvili, M. A. Sagirov, I. A. Argir

    This article reviews modern technologies for durable mechanical circulatory support (dMCS) —implantable devices that replace or support cardiac function. The process of improving circulatory support devices has spanned several decades. We have evolved from bulky first-generation pulsatile pumps to compact and reliable non-pulsatile flow pumps. Today, these highly effective systems are used in 95% of cases. Modern devices can serve not only as a bridge to heart transplantation for patients awaiting a donor organ, but also as ongoing therapy for patients who are not eligible for a heart transplant. At the same time, trends toward improving the quality of medical care are also impacting the refinement of existing circulatory support techniques: minimally invasive devices for full and partial cardiac support are being developed; fully magnetically levitated centrifugal-flow left ventricular assist devices are becoming dominant; solutions for right ventricular and biventricular failure, including the total artificial heart, are emerging. Sputnik portable circulatory support devices and STREAM CARDIO systems have been developed and are being used in Russia. They are comparable in efficacy and safety to their foreign counterparts, and in some respects (for example, antithrombogenic coating) they are superior. Their main advantage is their significantly lower cost and accessibility for Russian patients, which is critically important given the shortage of donor organs and the high cost of imported systems. DMCS has become a life-saving and life-preserving standard practice in cardiac surgery. Given current demographic conditions, the growing proportion of patients with heart failure, and the chronic shortage of donor organs, further development and cost reduction of the aforementioned technologies is a strategic necessity for this country.

  • Open Access

    Mechanical Circulatory Support in Patients with End-Stage Heart Failure: a Literature Review (Part 1)

    by M. Sh. Khubutiya, A. S. Tokarev, N. V. Rubtsov, M. V. Israpiev, L. G. Khutsishvili, M. A. Sagirov, I. A. Argir

    Chronic heart failure (CHF) is a progressive and irreversible syndrome that develops against the background of structural and functional disorders of the heart. It is accompanied by a decrease in cardiac output, pressure overload and a high level of hospitalizations, which makes CHF one of the key medical and social problems of our time. In recent decades, the prevalence of CHF has been steadily increasing, especially among the elderly population, which is associated with an increase in life expectancy and an improvement in the quality of medical care. According to forecasts, by 2050 the number of patients will increase by 50-60% compared to 2010.The terminal stage of CHF is characterized by an extremely unfavorable prognosis: survival does not exceed 25-30%. Heart transplantation (HT) remains the only radical treatment method that can significantly improve survival and quality of life. However, the shortage of donor organs and the growing number of patients necessitate the use of mechanical circulatory support (MCS) as a temporary or long-term alternative.MPC systems act as a “bridge” to transplantation, allowing for hemodynamic stabilization and organ function support before surgery. The most common short-term support technologies are extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), and temporary axial pumps (Impella, TandemHeart). ECMO provides both respiratory and hemodynamic support, but is associated with a high risk of complications and relatively low survival. IABP is the most accessible method, improving coronary perfusion, but provides limited support. Impella devices demonstrate higher efficiency, unloading the left ventricle and improving systemic hemodynamics, while being characterized by fewer complications. TandemHeart provides a comparable effect, but requires a more complex installation technique.The choice of MPC method depends on the patient’s condition, the severity of multiorgan dysfunction, the availability of equipment, and the qualifications of the specialists. Current research confirms that a combination of different devices (e.g., ECMO and Impella) can improve outcomes.Thus, mechanical circulatory support occupies a central place in the treatment of terminal heart failure in conditions of limited donor resources, allowing to gain time before transplantation and reduce mortality on the waiting list.


  • Open Access

    The Choice of Tactics for Surgical Treatment of Acute De Bakey Type I Aortic Dissection in a Multidisciplinary Surgical Hospital

    by А. В. Редкобородый, V. S. Selyaev, N. V. Rubtsov, L. S. Kokov, R. Sh. Muslimov, I. E. Popova, K. M. Torshkhoyev, L. G. Khutsishvili

    BACKGROUND Acute proximal aortic dissection (Stanford type A) remains the most common fatal pathology of the thoracic aorta. Despite the improvement of surgical technologies, hospital mortality after emergency surgical interventions is 17–25%, in complicated cases it can reach 80–90%.AIM OF STUDY Description of the perioperative treatment tactics adopted at the N.V. Sklifosovsky Research Institute for Emergency Medicine as well as the evolution of approaches that make it possible to obtain satisfactory hospital and long-term results in the treatment of aortic dissection.MATERIAL AND METHODS the study included 278 patients operated on from 2015 to 2021 in the acute stage of aortic dissection (less than 48 hours from the moment of manifestation of the disease). The operated patients were divided into two groups, depending on the presence of complicated forms: group A, 102 patients with uncomplicated course of the disease; group B, 176 patients with complicated course of the disease. Additionally, patients were divided depending on the level of distal reconstruction performed: group I, 83 patients, surgery was limited to prosthetics of the ascending aorta, without removing the clamp; group II, 137 patients who underwent hemi-arch surgery; group III, 58 patients, with distal reconstruction involving the aortic arch.RESULTS Total hospital mortality was 28.1%: 25.3% in group I, 29.1% in group II, 29.3% in group III. In the group of uncomplicated dissection, postoperative mortality was 18.6%, while in the group of complicated dissection it was 33.5%.CONCLUSION An integrated multidisciplinary approach with the formation of an “aortic team”, an individual approach to surgery, depending on the anatomy of the dissection and the clinical status of the patient, will improve the results of the treatment of acute aortic dissection, as the most severe and multiple organ pathology of the aorta.FINDING 1. Hospital mortality of complicated forms of dissection remains significantly higher — 33.5% versus 18.5% of uncomplicated course. 2. The most optimal method of distal reconstruction in patients with the peracute stage of dissection is an open anastomosis with the aorta using the “hemi-arch” technique. 3. If it is necessary to extend the surgical intervention on the aortic arch, a distal anastomosis in areas 0, 1, 2 with the possibility of a subsequent endovascular stage is the priority.


  • Open Access

    Neoaortic Bicuspid Valve Replacement in Patient After Arterial Switch Operation to Correct Dextro-Transposition of the Great Arteries

    by V. S. Selyaev, А. В. Редкобородый, N. V. Rubtsov, O. Yu. Kornoukhov, S. S. Niyazov, N. M. Bikbova, R. Sh. Muslimov

    INTRODUCTION Transposition of the great arteries is the second most common cyanotic congenital heart defect after tetralogy of Fallot. The arterial switch procedure (А. Jatene, 1975) is the surgical treatment of choice. Neoaortic root dilatation and valve regurgitation are quite common among the patients who underwent surgery for transposition of the great arteries. However, there are a lot of conflicting data about their direct connection.CLINICAL CASE This article describes surgical repair of neoaortic bicuspid valve regurgitation, by it successful implantation, in an 18-year-old patient after arterial switch operation for transposition of the great arteries in the neonatal period.CONCLUSION Neoaortic valve insufficiency can develop primarily as well as secondary to neoaortic root dilatation, however, the questions about valve repair or aortic root replacement with or without neoaortic valve implantation remains debatable. At this stage, decision making is based only on unsystematic clinical experience, surgeon’s intuition, the basics of anatomy and pathophysiology, as well as close interaction of “pediatric” and “adult” cardiac surgeons.


  • Open Access

    Clinical Case of Correction of an Acquired Gerbode Defect After Mitral Valve Replacement in a Patient With New Coronavirus Infection

    by M. V. Israpiyev, S. S. Niyazov, N. M. Bikbova, А. В. Редкобородый, N. V. Rubtsov, S. Yu. Kambarov, A. V. Kovalyov, L. S. Kokov, V. V. Vladimirov

    Clinical case. A patient after mitral valve replacement surgery for infective endocarditis was hospitalized with a new coronavirus infection. The examination revealed a left ventricular-right atrial communication. The complex treatment with a good clinical effect was performed at the N.V. Sklifosovsky Research Institute for Emergency Medicine. Conclusions In the context of a pandemic of a new coronavirus infection, patients with a new coronavirus infection who have undergone a history of heart surgery are subject to greater clinical vigilance regarding the development of postoperative complications, including rare ones.


  • Open Access

    The First Experience of Aortic Valve Repeated Replacement Using the “Valve in Valve” Technique in a Patient With Dysfunction of a Biological Prosthesis

    by V. V. Vladimirov, L. S. Kokov, A. I. Kovalyov, S. S. Niyazov, M. V. Parkhomenko, А. В. Редкобородый, N. V. Rubtsov, N. M. Bikbova, R. Sh. Muslimov

    Introduction. Aortic valve replacement in cardiopulmonary bypass with suture fixation of the prosthesis is the “gold standard” in cardiac surgery. Currently, the frequency of use of heart valve bioprostheses is increasing in older patients. Despite all the advantages of using heart valve bioprostheses, this type of prosthesis has a major drawback - it is not durable. In most cases, the reason for the dysfunction of prostheses in the late postoperative period is early calcification of the prosthesis valves or their rupture due to degeneration. With the development of new “gentle” techniques for replacing heart valves, transcatheter aortic valve implantation was introduced into clinical practice. The use of transcatheter aortic valve implantation (TAVI) “valve in valve” for reoperations in older patients is of great interest, since in recent years the procedure has been widely used in clinical practice and shows promising data in patients with high surgical risk.Aim of study. Show first experience of using a technique «valve in valve» at N.V. Sklifosovsky Research Institute for Emergency Medicine.Material and methods. The results of surgical treatment of a patient with aortic valve bioprosthesis dysfunction using the TAVI “valve in valve” technique are presented.Results. The use of the TAVI “valve in valve” method made it possible to perform reprosthetics of the aortic valve (AV) from a transfemoral approach, not to increase the volume of intervention during reoperation, to avoid trauma to the structures of the heart and nearby tissues when accessing the AV in a patient with a high surgical risk.Conclusion. The use of the TAVI “valve in valve” method in cardiac surgery makes it possible to achieve good immediate and long-term results when it is necessary to replace the AV in patients with a high surgical risk.

  • Open Access

    Acute Renal Injury in Cardiac Surgery Patients

    by S. I. Rey, G. A. Berdnikov, L. N. Zimina, N. V. Rubtsov, M. K. Mazanov, D. A. Kosolapov, V. V. Sokolov

    Background. Acute kidney injury following cardiac surgery remains a common and serious complication.Aim of study. To identify risk factors for the development and morphological features of acute renal injury, to assess the use of renal replacement therapy in patients after cardiac surgery.Material and methods. The study involved 66 patients who were treated in the Department of Cardiac Resuscitation of the N.V. Sklifosovsky Research Institute for Emergency Medicine from 2009 to 2018. Of these, 45 men (68.2%) and 21 women (31.8%). The mean age of the patients was 56.3±13.2 years. Clinical and anatomical analysis of material from 19 deceased patients was carried out. Depending on the use of methods of renal replacement therapy, patients were divided into two groups: Group 1 included 23 patients with acute renal injury requiring the use of renal replacement therapy; Group 2 included 43 patients where methods of renal replacement therapy were not used.Results. Hospital mortality in Group 1 was lower (34.8 and 41.9%, respectively), however, the differences were statistically insignificant (p=0.372). To identify the factors in the development of acute renal damage, a stepwise regression analysis was performed by constructing a regression model of Cox proportional hazards. Age, history of chronic kidney disease, serum creatinine level on the first day after surgery, severity of the condition according to the APACHE-II scale, increased lactate level on day 2 of the postoperative period, decreased urine output on the first day after surgery were statistically significant.Conclusion. Risk factors for the development of ARI after cardiac surgery under cardiopulmonary bypass are advanced age, CKD in history, the severity of the patient’s condition, assessed by the APACHE-II scale, increased serum creatinine on the first day after surgery, increased lactate on day 2 of the postoperative period, a decreased diuresis on day 1 after surgery. The use of RRT in patients after surgery under the conditions of AC was accompanied by a tendency to improve treatment results: in-hospital mortality in the group of patients who underwent RRT was 34.8% versus 41.9% in the group without RRT methods. Morphological and functional features of renal failure in patients with ARI were preceding chronic renal pathological processes of different etiology, mainly affecting the glomeruli, vessels and stroma, as well as acute pathological processes aggravating ARI (dyscirculatory disorder, degenerative changes, necrosis and necrobiosis tubular epithelium).


  • Open Access

    Multi-component reconstructive heart surgery as an alternative to transplantation in a patient with combined cardiac pathology and critically low left ventricular contractility

    by V. V. Sokolov, A. V. Redkoborodyy, N. V. Rubtsov, L. G. Khutsishvili, E. N. Ostroumov, E. V. Migunova, N. M. Bikbova

    Introduction. Cardiovascular diseases rank leading in the world. The decompensation of chronic heart failure is the direct cause of death in most patients. The choice of a definitive treatment tactics is the key factor in these patients.Clinical case. A patient who had experienced myocardial Q-infarction with an ST segment elevation of anterior septal location complicated by the left ventricle anterior wall aneurysm and a decreased myocardial contractility was hospitalized with subcompensated chronic heart failure. Previously, and initially with that hospitalization, the patient was considered a candidate for heart transplantation. After the examination, a decision was made on the possibility of a multi-component reconstructive heart surgery, which was performed with a good clinical effect.Conclusion. The presented clinical case has confirmed the possibility of correcting the combined pathology in a patient with low myocardial contractility obtaining good immediate and long-term (1.5 years after surgery) results.